Overall Technical outlook

Price Summary

J. B. Chemicals & Pharmaceuticals Limited's stock began trading at 2061.2 on 2026-04-30, soared to 2072.9, dipped to 2028.7, and finished the day -0.86% lower at 2043.4, with 145230 shares exchanged.
The stock reached its highest price of 2138.6 and its lowest price of 1504.4 during the 52-week period.
The future price of JBCHEPHARM is projected to range from 1900.0 to 2550.0, with an average expected price of 2243.0, according to 9 analysts.

Technicals

Support and Resistance: The current price for JBCHEPHARM is 2043.4, supported at 1998.4 with resistance at 2081.4. This indicates a trading range where 1998.4 might prevent further declines, while 2081.4 could hinder additional gains.
JBCHEPHARM supportResistance e68139
Support/Resistance for JBCHEPHARM


Aroon: The AROON is in a neutral stance, with no clear signals for movement up or down. This neutral position indicates a potential period of consolidation or uncertainty in the market.
JBCHEPHARM aroon e68139
Aroon chart for J. B. Chemicals & Pharmaceuticals Limited


Bol. Bands: The price's drop under the upper Bollinger Band suggests a possible downward movement. This signal may indicate that the recent uptrend is losing strength, and a decline could follow. Traders often view this as an overbought condition, where a price correction is likely, making it an essential moment to consider potential adjustments to trading positions.
JBCHEPHARM bbands e68139
Bolinger Bands chart for J. B. Chemicals & Pharmaceuticals Limited


Parabolic SAR: The PSAR remains bullish, establishing a key support level that could help uphold the market's upward trajectory. This persistent bullish outlook suggests that the market may continue to rise, with the support providing a foundation for further gains.
JBCHEPHARM psar e68139
Parabolic Stop and Reverse chart for J. B. Chemicals & Pharmaceuticals Limited


Stochastic: The STOCHASTIC is showing a neutral stance, not indicating a clear upward or downward trend for J. B. Chemicals & Pharmaceuticals Limited. This suggests a period of market balance, where neither side is showing dominance.
JBCHEPHARM stoch e68139
Stochastic chart for J. B. Chemicals & Pharmaceuticals Limited


Tripple Moving Agerage: The current state of the Tripple MOVING AVG is neutral, with no clear trend direction indicated. This lack of directional bias suggests that the market may be in a phase of consolidation or uncertainty.
JBCHEPHARM trippleSMA e68139
Tripple SMA chart for J. B. Chemicals & Pharmaceuticals Limited


A comprehensive approach to analyzing a company requires considering both its technical and fundamental aspects. The company's fundamentals, such as its earnings, growth prospects, and financial health, provide a strong foundation for understanding technical indicators. Additionally, examining the industry it operates in helps contextualize the company's position within the broader market. By integrating these factors, one can gain more valuable insights into the company's stock performance and potential investment opportunities.